Skip to content
Adopted text

Genetically modified maize DP51291

TA-10-2025-0222 · P10_TA(2025)0222 · PE775.588

Official HTML ↗ PDF DOCX
✦ In shortFull text
✦ In short · AI summary of this text, generated 4 Sept 2026

Written by a language model from the full text only; every figure comes from the text. The paragraph links open the paragraph a statement rests on — check the text itself before relying on it.

Parliament's resolution objects to Commission Implementing Decision (EU) 2025/1898 authorising genetically modified maize DP51291, considering it exceeds implementing powers and is inconsistent with Union law. It calls on the Commission to repeal the decision, submit a new draft, ensure standards convergence in trade negotiations, and not authorise the maize due to risks to biodiversity, food safety and workers' health. It also urges the Commission to take into account international obligations and deliver on commitments regarding hazardous chemicals.

Key points

  1. Considers that Implementing Decision (EU) 2025/1898 exceeds the implementing powers provided for in Regulation (EC) No 1829/2003.
  2. Considers the decision inconsistent with Union law, as it is not compatible with the aim of Regulation (EC) No 1829/2003 to ensure a high level of protection of human life and health, animal health and welfare, and environmental and consumer interests.
  3. Calls on the Commission to repeal Implementing Decision (EU) 2025/1898 and submit a new draft to the committee.
  4. Calls on the Commission to ensure convergence of standards between the Union and its partners in free trade agreement negotiations to meet Union safety standards.
  5. Calls on the Commission not to authorise the GM maize due to increased risks to biodiversity, food safety and workers' health in line with the One Health approach.
  6. Expects the Commission to deliver on its commitment to propose ensuring hazardous chemicals banned in the Union are not produced for export.
  7. Welcomes the Commission's recognition of the need to take sustainability into account in GMO authorisation decisions, but expresses disappointment that it has continued to authorise GMOs despite objections.
  8. Urges the Commission to take into account Union obligations under international agreements such as the Paris Climate Agreement, the UN CBD and the UN SDGs, and reiterates the call for explanatory memoranda upholding the 'do no harm' principle.

Who is affected

  • The Commission, which is called on to repeal the decision and change its approach to GMO authorisations.
  • Union farmers, who face competitive disadvantage from imports not complying with Union standards.
  • Corteva Agriscience LLC, the applicant for authorisation, whose data is not independently verified.

Figures and deadlines

  • 113 base pairs of maize genomic DNA deleted by the genetic modification process.
  • Five novel open reading frames showed greater than 35 % sequence identity to known allergens.
  • Field trials conducted over a single growing season (2021) in the United States and Canada.
  • Glufosinate approval expired on 31 July 2018.
  • UN SDG Target 3.9 aims by 2030 to substantially reduce deaths and illnesses from hazardous chemicals and pollution.
  • Kunming-Montreal Global Biodiversity Framework includes a target to reduce pesticide risk by at least 50 % by 2030.